Home

Welcome to NLS Pharma

We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity. We are creating new approaches to treat mental and behavioral disorders, and to enhance cognitive function in healthy people.

Founders

Our multidisciplinary Team, led by professionals with a long track record in drug development and management, relies on highly skilled personnel with unique competence in developing integrated solutions.

Latest News

  • May 16, 2017
    NLS Pharma announces phase 2 study of NLS-1 (MAZINDOL) in adult ADHD patients has met all primary and secondary endpoints
  • April 20, 2017
    NLS Pharma Announces Presentations at 6th World Congress on ADHD
  • April 18, 2017
    NLS Pharma Announces Completion of Phase 2 Study for NLS-1, Its Lead ADHD Compound; New Investors, New Patents
  • December 4, 2016
    NLS Pharma Named Winner Of A Prestigous 2016 Healthcare & Life Sciences Award
Contact us

NLS Pharma is very interested in hearing from you. Please find general contact information below.

NLS PHARMA GROUP
Alter Postplatz 2
CH-6370 Stans NW
Switzerland

T: +41 41 618 80 00
F: +41 41 618 80 09
askus@nls-pharma.com

Your Name (required)

Your Email (required)

Subject

Your Message